COVID-19 Impact Analysis on Europe Cleanroom Technology Market. Insights on Strategies of Key Players

The rising incidence of infectious diseases is one of the key factors resulting in the increasing demand for the cleanroom technology in Europe. As per the European Centre for Disease Prevention and Control (ECDC), human immunodeficiency virus (HIV) infection is one of the most prevalent diseases in the region, with almost 30,000 new cases recorded every year. It was reported that approximately 29,444 people were suffering from HIV in 31 countries of the European Union (EU) in 2016. The other most common diseases prevalent in the region are hepatitis B, respiratory tract infections, and tuberculosis, which is raising the demand for drugs and medical devices.

Due to the above-mentioned factors, the revenue generated from the sale of cleanroom consumables and equipment in Europe is predicted to increase from $1,126.6 million in 2017 to $1,701.8 million by 2023. The Europe cleanroom technology market is additionally expected to advance at a CAGR of 7.2% during the forecast period (2018–2023). Between consumables and equipment, consumables are expected to register faster growth in requirement during the forecast period, owing to their rising adoption, in order to maintain a contamination-free environment in hospitals, research laboratories, and pharmaceutical, medical devices, and biotechnology industries.

Request for sample copy of this report@ http://bit.ly/2JT1P0q

In Europe, pharmaceutical production is increasing at a rapid rate, mainly due to the rising demand for drugs, on account of the increasing prevalence of chronic diseases and surging geriatric population. As per the EFPIA, the region reported pharmaceutical production worth $337,825 million in 2016. Apart from pharmaceutical, cleanrooms are required in the medical devices and biotechnology industries. Out of these, the pharmaceutical industry recorded the highest usage of cleanroom consumables and devices in 2017, primarily due to the rising number of pharmaceutical companies in Europe, which are mandated to have cleanrooms.

Germany recorded the highest adoption of the cleanroom technology in Europe in the past, and this trend is expected to continue during the forecast period. This is mainly attributed to the increasing number of cleanroom technology providing companies and ballooning incorporation of cleanroom products in the biotechnology and pharmaceutical companies in the country. France is predicted to register the fastest growth in the adoption of the cleanroom technology in the continent in years to come, owing to the presence of numerous companies offering and using these solutions. As a result, the European cleanroom technology market will grow rapidly in France.

Hence, it is clear that owing to the burgeoning demand for a pollutant- and contaminant-free environment in the pharmaceutical, biotechnology, and medical devices industries and increasing awareness regarding hygiene and sterilization, the demand for cleanrooms will rise in Europe in future.

Read more: https://www.psmarketresearch.com/market-analysis/europe-cleanroom-technology-market

Read More

What are Key Factors that will Shape Growth of Europe Drug of Abuse Testing Market till 2023?

With the rapid rise of drug of abuse testing in Europe, technological advancements in the field, growing alcohol and drug consumption amongst the youth, and the consequent increase in addiction problems, the European DOA testing market is expected to generate $3.0 billion revenue by 2023. The market is predicted to witness a CAGR of 9.6% during the forecast period (2018–2023), which will contribute toward its huge revenue increase, from the $1.7 billion recorded in 2017.

Request for sample copy of this report@ http://bit.ly/2WefFOB

The high alcohol and drug consumption rates in Eastern and Western Europe, as a result of the rapid rise in the disposable income, have created a serious problem. As per a report by the World Health Organization (WHO), the mortality and disability rates in Eastern Europe, in particular, are much higher than that of Western Europe. For instance, Russia and some of its neighboring countries are witnessing excessively grave alcohol and drug abuse problems, thereby driving the growth of the European DOA testing market.

Depending on type, the European DOA testing market is bifurcated into products and services. The products bifurcation is further categorized into equipment and consumables, with the equipment subcategory including the various devices used for drug testing, such as breath analyzers, chromatography instruments, and immunoassay analyzers. The consumables subcategory comprises the products used for the testing of the intake of illicit drugs, such as cocaine, heroin, marijuana, and methadone. Overall, the services sector is projected to generate revenue of more than $600.0 million by 2023, growing with the higher CAGR, of 11.1%, during the forecast period.

Some of the major trends in the European DOA testing market are the growing mergers and acquisitions and the rapidly increasing number of drug testing innovations. The acquisition of Medical Laboratory Bremen, a laboratory located in north-western Germany, by Sonic Healthcare Limited, in January, 2017, is an example of the increasing number of acquisitions shaping the market. The main reason behind this acquisition was the company’s increasing focus toward expanding its market in Germany, along with strengthening its commitment to medical leadership in laboratory medicine.

In 2017, the market was dominated by the U.K., with a revenue contribution of $276.0 million, which is also projected to display the highest CAGR, of 11.0%, during the forecast period. The high alcoholism and drug use rate and increasing awareness among the people about easy testing methods are fueling the industry prosperity in the kingdom. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) claimed that the country has the highest cannabis consumption, in 2017.

Thus, the rapid growth in drug and alcohol consumption in Europe and the steps taken by various regulatory bodies and governments to counter this will ensure the progress of the market.

Read more: https://www.psmarketresearch.com/market-analysis/europe-doa-testing-market

Read More

How is Rising Prevalence of Hospital-Acquired Infections Driving Hospital Infection Therapeutics Market?

Hospitals or other medical facilities are particularly associated with the treatment of diseases and the idea of getting infected with a pathogen while being in the hospitals may be quite foreign to a lot of people. However, hospital infections or hospital-acquired infections affect a lot of people; for example, according to the World Health Organization, of every 100 patients that are hospitalized, at any given time, about 10 in developing and 7 in developed counties will acquire at least one hospital infection. In addition to this, newborns especially are at a higher risk of suffering from healthcare associated disease in emerging economies.

Request for sample copy of this report@ http://bit.ly/2AXVcpy

Some of the hospital infections are catheter-associated urinary tract infections, central line-associated blood stream infections, hospital-acquired pneumonia, surgical site infections, Clostridium difficile infections, and ventilator-associated pneumonia. Much like any other infection, the risk of hospital infections depends on the patient’s immune status. Other than this, prevalence of several pathogens in the local community and infection control practices are also major factors on which hospital infection depend. Some of the major risk factors for these infections include longer hospital stays, older age, multiple underlying chronic illnesses, recent invasive procedures, immunosuppression, frequent encounters with healthcare facilities, and mechanical ventilatory support.

Because of these reasons, the need for preventing and treating hospital infections is growing, which is why the hospital infection therapeutics market is expected to register substantial growth in the coming years. Hospital infections are caused by viral, bacterial, and fungal pathogens, due to which a number of antiviral, antibacterial, and antifungal drugs have been developed. Among these, the largest demand is predicted to be created for antibacterial drugs in the near future. Pneumonia was the most prevalent hospital infection in the past and the prevalence of hospital acquired urinary tract infection is also projected to grow considerably in the coming years.

Geographically, North America has emerged as the largest hospital infection therapeutics market in the past few years, which is attributed to the enhanced healthcare infrastructure, increased awareness regarding healthcare, high ratio of hospitals in comparison to the population, surging aging population, and rising count of multi drug resistant microbial pathogens in the region. Apart from this, the demand for hospital infection therapeutics is also expected to increase significantly in the Asia-Pacific region because of the rising incidence of hospital infections and high requirement for therapeutic drugs in countries including China and India.

In conclusion, the demand for hospital infection therapeutics is growing due to the rising incidence of hospital infections.

Read more: https://www.psmarketresearch.com/market-analysis/hospital-infection-therapeutics-market

Read More

How is Changing Preference of Patients Driving Telemedicine Market?

The access to proper healthcare facilities is something which should be available for each and every person; however, people living at remote locations are often left out when it comes to provision of advanced healthcare facilities. This is because developed healthcare infrastructure is only present in cities and densely populated areas. Attributed to these, the concept of telemedicine was developed for treating patients who were located in remote areas, in areas with shortages of medical professionals, or far away from local health facilities. Telemedicine at the present time is also utilized for addressing similar concerns, but the preference of consumers is changing as well, which is further resulting in a rising need for telemedicine.

As per a P&S Intelligence report, the global telemedicine market size reached a value of $21.5 billion in 2017 and is expected to generate a revenue of $48.8 billion by 2023, progressing at a 14.8% CAGR during the forecast period (2018–2023).

Request for sample copy of this report@ http://bit.ly/2q9LzMx

The major services offered by the telemedicine technology are tele-training, tele-consulting, tele-education, and tele-monitoring. The largest demand in the coming years is projected to be created for tele-monitoring services in the coming years, which is ascribed to the rising need for patient monitoring services in remote areas.

The need for tele-hospital and clinic type was larger in the past, owing to the surging prevalence of health conditions associated with lifestyle changes. Apart from this, the tele-home services are also projected to gain traction in the near future because of patient benefits, such as shorter hospital stays, remote monitoring of health conditions, and enhanced access to healthcare professionals. Telemedicine services are offered on the basis of different specialties, namely orthopedics, dermatology, neurology, gynecology, and cardiology. Telemedicine was used the most for dermatology in the past, which is attributed to the growing prevalence of skin diseases and increasing healthcare expenditure.

Geographically, North America has been the largest user of the telemedicine technology in 2017 due to the advanced healthcare infrastructure, rising spending in the healthcare sector, growing prevalence of skin and chronic diseases, and presence of major companies in the region. Other than this, the Asia-Pacific (APAC) region is predicted to emerge as the fastest growing telemedicine market in the coming years, which is attributed to the rising adoption of technologically advanced products and rapidly improving healthcare infrastructure in the region. In addition to this, the geriatric population is also growing in APAC, primarily in Japan, which is further expected to lead to growing adoption of telemedicine.

In conclusion, the need for telemedicine is rising for providing access to better medical facilities to patients in remote locations.

Read More